Wordt geladen...
Immunotherapy for hematological malignancies
Tumor immune tolerance remains a major barrier for effective anti-cancer therapy. A growing number of pathways whereby solid tumors escape immune surveillance have been characterized (1). This progress led us to revisit the “hallmarks of cancer” and brought forward many promising immunotherapies. Ev...
Bewaard in:
| Gepubliceerd in: | J Life Sci (Westlake Village) |
|---|---|
| Hoofdauteurs: | , |
| Formaat: | Artigo |
| Taal: | Inglês |
| Gepubliceerd in: |
2019
|
| Onderwerpen: | |
| Online toegang: | https://ncbi.nlm.nih.gov/pmc/articles/PMC6709701/ https://ncbi.nlm.nih.gov/pubmed/31453573 |
| Tags: |
Voeg label toe
Geen labels, Wees de eerste die dit record labelt!
|